Indications for 2024
By Health Capital Consultants, LLC
***
***
After healthcare mergers and acquisitions (M&A) activity began to regain momentum in 2022, following the slowing of deals in the wake of the COVID-19 pandemic, transactional activity continued to accelerate in 2023. While the healthcare sector continued to be impacted by factors such as valuation gaps, higher-for-longer interest rates, general macroeconomic risks, and increased state and federal regulatory concerns in 2023, the outlook for 2024 remains cautiously optimistic.
CITE: https://www.r2library.com/Resource
This Health Capital Topics article reviews the U.S. healthcare industry’s 2023 M&A activity and discusses what these trends may mean for 2024. (Read more…)
COMMENTS APPRECIATED
Thank You
***
***
Filed under: "Ask-an-Advisor", "Doctors Only", Career Development, Experts Invited, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, Op-Editorials | Tagged: Health Capital Consultants LLC, M&A, mergers, Mergers & Acquisitions, mergers and acquisitions | Leave a comment »














